Crossmark

Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients

Published Online: 2021-09-09

Authors

Lapoirie, J.

Tran, L.

Piazza, L.

Contin-Bordes, C.

Truchetet, M. E.

Bonnet, F.
License Information

Text and Data Mining valid from 2021-09-09

Version of Record valid from 2021-09-09
More Information

Article History

Received: 25 March 2021

Accepted: 18 August 2021

First Online: 9 September 2021

Competing interests

: The authors declare no competing interests.

Document is current